Biogen Idec

URI: https://gptkb.org/entity/Biogen_Idec
GPTKB entity
Statements (42)
Predicate Object
gptkbp:instance_of gptkb:biotechnology
gptkbp:acquisition gptkb:Zymeworks
gptkb:Acorda_Therapeutics
gptkb:Idec_Pharmaceuticals
gptkb:Onco_Immune
Nightstar Therapeutics
gptkbp:ceo gptkb:Michel_Vounatsos
gptkbp:clinical_trial gptkb:amyotrophic_lateral_sclerosis
gptkb:muscular_dystrophy
gptkb:neurodegenerative_diseases
gptkb:multiple_sclerosis
gptkbp:employees 7,000+
gptkbp:founded gptkb:1978
gptkbp:founder gptkb:M._A._(Marty)_Houghton
gptkbp:headcount 7,500 (2021)
gptkbp:headquarters gptkb:Cambridge,_Massachusetts
https://www.w3.org/2000/01/rdf-schema#label Biogen Idec
gptkbp:industry gptkb:biotechnology
gptkbp:market_cap $40 billion (2021)
gptkbp:notable_work gptkb:Eptinezumab
gptkb:Nusinersen
gptkb:Aducanumab
gptkb:Diroximel_Fumarate
gptkb:Lecanemab
gptkbp:partnership gptkb:Samsung_Bioepis
gptkbp:products gptkb:Tecfidera
gptkb:Avonex
gptkb:Tysabri
gptkbp:research_focus neurological diseases
gptkbp:revenue $13.45 billion (2020)
gptkbp:stock_symbol gptkb:BIIB
gptkbp:subsidiary gptkb:Biogen_Idec_Ltd.
gptkb:Biogen_Idec_MA_Inc.
gptkb:Biogen_Idec_Australia_Pty_Ltd.
gptkb:Biogen_Idec_Japan_Ltd.
gptkb:Biogen_International_Gmb_H
gptkb:Biogen_Idec_Canada_Inc.
gptkbp:traded_on gptkb:NASDAQ
gptkbp:website www.biogen.com
gptkbp:bfsParent gptkb:Biogen
gptkb:urban_park
gptkbp:bfsLayer 4